BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2015
View Archived Issues
Novel small-molecule inhibitors confirm the involvement of PADI4 in neutrophil trap formation
Read More
FRAXA grant to Neurotrope preclinical behavioral studies of bryostatin for fragile X syndrome
Read More
AGTC and 4DMT collaborate in AAV-gene therapies for ophthalmic diseases
Read More
Curadev partners with Roche on IDO-1 and TDO inhibitors
Read More
FDA grants priority review to Adcetris supplemental BLA
Read More
FDA assigns obinutuzumab orphan drug status for follicular lymphoma
Read More
U.S. orphan drug status conferred on triheptanoin for fatty acid oxidation disorders
Read More
Preclinical evaluation of the selective FGFR inhibitor INCB-054828
Read More
FP-208, an mTOR inhibitor, shows potential for cancer in preclinical studies
Read More
An orally available MKNK1 inhibitor from Bayer
Read More
TetraLogic and Merck & Co. to collaborate on phase I trial of birinapant and pembrolizumab
Read More
Novel zefrafish model for detecting apoptosis
Read More
Euroscreen starts phase II trials of ESN-364 in uterine fibroids and polycystic ovary syndrome
Read More
SHAL Technologies receives NCI grant to fund preclinical testing of SH-7139
Read More
Uric acid as a novel predictive biomarker in ankylosing spondylitis
Read More
Pain Therapeutics regains rights to Remoxy from Pfizer
Read More
Nimbus Discovery patents IRAK-4 inhibitors
Read More
Pfizer's crizotinib receives FDA breakthrough therapy designation for ROS1-positive NSCLC
Read More
Pharmakea discloses autotaxin inhibitors
Read More
Astex Therapeutics develops prodrugs of gemcitabine and cytarabine
Read More
Olatec Industries patents compound for pain and inflammation
Read More
Sanford-Burnham Medical Research Institute patent describes EBI2 modulators
Read More
Relmada initiates proof-of-concept study for oral buprenorphine
Read More
scPharmaceuticals initiates pivotal trial of furosemide solution for subcutaneous administration
Read More
Inovio initiates phase I trial of HBV DNA vaccine INO-1800
Read More
Teva makes play for Mylan as Perrigo rejects Mylan proposal
Read More